We are proud to announce that our partner, the Central Research Laboratory at Kempegowda Institute of Medical Sciences in Bangalore, was awarded the world’s first Good Financial Grant Practice (GFGP) Certification on 15 June 2020.
Over 30 years of laboratory-based surveillance of antimicrobial resistance (AMR) in the Philippines has highlighted the increasing rates of drug-resistant bacterial pathogens.
Pathogen surveillance is a crucial part of early-stage and ongoing responses to COVID-19. The UK consortium on COVID-19 genomics (COG) aims to link local sequencing centres with large scale facilities from across the UK to apply real-time genomic epidemiology to our understanding and ability to respond to the pandemic.
Our study in Nature Microbiology indicates that the major driver of the carbapenem resistant K. pneumoniae epidemic in Europe has been transmission of hospital-adapted clones through healthcare networks.
Combining the strengths of the European Centre for Disease Prevention and Control, the Wellcome Sanger Institute and the Centre for Genomic Pathogen Surveillance will improve the monitoring and tracking of infectious disease across Europe.
A WHO Technical Note has been published that will enable health authorities to make informed choices on the most appropriate molecular tests in order to achieve a clearer picture of antimicrobial resistance globally.
We outline our recent experience with public engagement — what we did and what we learned.
Establishing a network for genomic surveillance of Staphylococcus aureus in South America.
Genomic approach could help doctors monitor emerging resistance and prescribe most effective antibiotics in the future.
CGPS to house the Global Health Research Unit to monitor antibiotic resistant bacteria around the globe.